
To define the maximum tolerated dose zzso zzso and efficacy of zzso chemotherapy with zzso in patients with liver zzso of zzso zzso zzso 

zzso zzso zzso was applied on days 1, 14, 28 and zzso The initial dose was 140 zzso with escalation in the subsequent patient group to 160 zzso The final protocol toxicity evaluation was 260 zzso Patients required zzso proven disease and adequate bone zzso liver and zzso function, no zzso zzso and a life expectancy zzso zzso zzso zzso patients were enrolled zzso age 65, range zzso zzso On dose level VI zzso zzso 1 case of zzso toxicity zzso zzso was observed, leading to an enlarged cohort of 6 zzso As no additional zzso was detected on this level, an escalation to level zzso was zzso On the dose level of 260 zzso zzso zzso were observed, resulting in the termination of escalation and the declaration of dose level VI as zzso Imaging follow-up with Response zzso zzso in Solid zzso zzso criteria revealed a complete response in 1 patient, stable disease in 31 patients, and progressed disease in 1 zzso The median time to progression was zzso months, the median overall survival zzso zzso 

The method of zzso chemotherapy with zzso is well tolerated and shows promising local response rates in liver zzso of zzso 

